-
3 US Generics Exporter, Anti-Infectives Franchise Owner and Biggest Indian Drug Maker by Value Stocks With a Strong Future Roadmap: Alembic Pharmaceuticals, Alkem Laboratories and Sun Pharma
- October 29, 2026
- Posted by: Neeraj Pandey
- Category: Best Stocks
No Comments
Generics, Anti-infective and Pharma Leader with a strong future roadmap: Alembic Pharmaceuticals, Alkem Laboratories and Sun Pharma. Compare price, valuation, return on equity and revenue growth as of 27 October 2026.
-
3 Anti-Infectives and Gastro Brands Leader, Research-Driven Pharma Company and Contract Formulations Producer Stocks With a Strong Future Roadmap: Alkem Laboratories, Glenmark Pharmaceuticals and Innova Captab
- October 27, 2026
- Posted by: Ankit Jaiswal
- Category: Best Stocks
Acute Care Brand, Research and Contract Stocks with a strong future roadmap: Alkem Laboratories, Glenmark Pharmaceuticals and Innova Captab. Compare price, valuation, return on equity and revenue growth as of 26 October 2026.
-
3 Branded Generics Marketer, Anti-Infectives and Gastro Leader and Custom Synthesis Ingredients Leader Stocks With a Strong Future Roadmap: Emcure Pharmaceuticals, Alkem Laboratories and Divi’s Laboratories
- October 27, 2026
- Posted by: Neeraj Pandey
- Category: Best Stocks
Branded Generics, Acute Care and API Stocks with a strong future roadmap: Emcure Pharmaceuticals, Alkem Laboratories and Divi’s Laboratories. Compare price, valuation, return on equity and revenue growth as of 26 October 2026.
-
3 Chronic Therapy Brands Company, Domestic Acute Care Leader and Active Ingredients Producer Stocks With a Strong Future Roadmap: Eris Lifesciences, Alkem Laboratories and Granules India
- October 26, 2026
- Posted by: Kunal Singla
- Category: Best Stocks
Chronic, Acute Care and Ingredient Pharma Stocks with a strong future roadmap: Eris Lifesciences, Alkem Laboratories and Granules India. Compare price, valuation, return on equity and revenue growth as of 23 October 2026.
-
3 Specialty Pharma Maker, Global Generics Leader and Branded Medicines Company Stocks With a Strong Future Roadmap: JB Chemicals and Pharmaceuticals, Dr. Reddy’s Laboratories and Alkem Laboratories
- October 26, 2026
- Posted by: Neeraj Pandey
- Category: Best Stocks
Branded Pharma and Specialty Generics Stocks with a strong future roadmap: JB Chemicals and Pharmaceuticals, Dr. Reddy’s Laboratories and Alkem Laboratories. Compare price, valuation, return on equity and revenue growth as of 23 October 2026.
-
3 Anti-Infective and Gastro Franchise, Latin America Branded Generics and Respiratory Leader Stocks With a Strong Future Roadmap: Alkem Laboratories, Caplin Point Laboratories and Cipla
- October 23, 2026
- Posted by: Lakshit Sharma
- Category: Best Stocks
Branded Pharma and Emerging Market Stocks with a strong future roadmap: Alkem Laboratories, Caplin Point Laboratories and Cipla. Compare price, valuation, return on equity and revenue growth as of 22 October 2026.
-
3 Oncology Generics, Acute Therapy Franchise and Pain and Anti-Malarial Brands Stocks With a Strong Future Roadmap: Natco Pharma, Alkem Laboratories and Ipca Laboratories
- October 22, 2026
- Posted by: Chaitanya Auti
- Category: Best Stocks
Complex Generic and Pain Care Stocks with a strong future roadmap: Natco Pharma, Alkem Laboratories and Ipca Laboratories. Compare price, valuation, return on equity and revenue growth as of 21 October 2026.
-
3 Custom API Manufacturing, Specialty Formulations and Acute Therapy Brands Stocks With a Strong Future Roadmap: Neuland Laboratories, Rubicon Research and Alkem Laboratories
- October 22, 2026
- Posted by: Chaitanya Auti
- Category: Best Stocks
API and Formulation Growth Stocks with a strong future roadmap: Neuland Laboratories, Rubicon Research and Alkem Laboratories. Compare price, valuation, return on equity and revenue growth as of 21 October 2026.
-
3 Acute Therapy Franchise, Chronic Care Leader and Regulated Market Generics Stocks With a Strong Future Roadmap: Alkem Laboratories, Torrent Pharmaceuticals and Strides Pharma Science
- October 21, 2026
- Posted by: Harsh Piplani
- Category: Best Stocks
Pharma Franchise Stocks with a strong future roadmap: Alkem Laboratories, Torrent Pharmaceuticals and Strides Pharma Science. Compare price, valuation, return on equity and revenue growth as of 20 October 2026.
-
3 Respiratory Generics, Eye Care Brands and Anti-Infective Franchise Stocks With a Strong Future Roadmap: Lupin, Ajanta Pharma and Alkem Laboratories
- October 21, 2026
- Posted by: Chaitanya Auti
- Category: Best Stocks
Branded Pharma Stocks with a strong future roadmap: Lupin, Ajanta Pharma and Alkem Laboratories. Compare price, valuation, return on equity and revenue growth as of 20 October 2026.
- 1
- 2